⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Two Different Doses of Cabozantinib (XL184) in Progressive, Metastatic Medullary Thyroid Cancer

Official Title: A Randomized, Double-blind Study To Evaluate the Efficacy and Safety of Cabozantinib (XL184) at 60 mg/Day Compared to a 140 mg/Day in Progressive, Metastatic Medullary Thyroid Cancer Patients

Study ID: NCT01896479

Study Description

Brief Summary: The objective of this study is to evaluate the efficacy and safety of oral cabozantinib at a 60 mg dose compared with a 140 mg dose in subjects with progressive, metastatic MTC. It will test if the lower dose results in similar progression free survival (PFS) and overall response rate (ORR) with fewer adverse events compared to the PFS, ORR and adverse events found in previous clinical trials of 140 mg.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, St. Leonards, New South Wales, Australia

, Herston, Queensland, Australia

, Kurralta Park, South Australia, Australia

, Parkville, Victoria, Australia

, Québec, Quebec, Canada

, Toronto, , Canada

, Osijek, , Croatia

, Zagreb, , Croatia

, Zagreb, , Croatia

, Bordeaux, Gironde, France

, Angers, Maine-et-Loire, France

, Lyon, Rhône, France

, Villejuif, Val-de-Marne, France

, Dijon, , France

, Paris, , France

, Strasbourg Cedex, , France

, Budapest, , Hungary

, Debrecen, , Hungary

, Jerusalem, , Israel

, Petach Tikva, , Israel

, Safed, , Israel

, Catania, CT, Italy

, Roma, RM, Italy

, Sienna, SI, Italy

, Pisa, Toscana, Italy

, Milano, , Italy

, Padua, , Italy

, Torino, , Italy

, Goyang, Gyeonggido, Korea, Republic of

, Seoul, , Korea, Republic of

, Seoul, , Korea, Republic of

, Amsterdam, Noord Holland, Netherlands

, Leiden, Zuid-Holland, Netherlands

, Groningen, , Netherlands

, Gliwice, Slaskie, Poland

, Poznań, Wielkopolskie, Poland

, Bucharest, , Romania

, Bucharest, , Romania

, Cluj-Napoca, , Romania

, Timisoara, , Romania

, Novosibirsk, , Russian Federation

, Obninsk, , Russian Federation

, St. Petersburg, , Russian Federation

, Yaroslavl, , Russian Federation

, Barcelona, , Spain

, Madrid, , Spain

, Madrid, , Spain

, Lund, Skane Ian, Sweden

, Uppsala, Uppsala Ian, Sweden

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: